Tesamorelin is a stabilized growth hormone-releasing hormone (GHRH) analog research peptide containing the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification for extended stability in laboratory studies.
Tesamorelin is a synthetic GHRH analog research peptide comprising the complete native GHRH sequence with an added trans-3-hexenoic acid group that protects it from enzymatic degradation. This extended stability makes it a dependable tool for studying growth hormone axis signaling, pituitary response, and downstream IGF-1 pathways over longer experimental windows.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution with bacteriostatic water and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Tesamorelin is a stabilized growth hormone-releasing hormone (GHRH) analog research peptide containing the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification for extended stability in laboratory studies. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
Every batch of Tesamorelin is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.